Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 3
2010 2
2013 2
2014 3
2015 3
2016 3
2018 1
2019 3
2020 2
2021 1
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Nephrotic syndrome 15"
Page 1
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.
Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D; International Pediatric Nephrology Association. Trautmann A, et al. Pediatr Nephrol. 2023 Mar;38(3):877-919. doi: 10.1007/s00467-022-05739-3. Epub 2022 Oct 21. Pediatr Nephrol. 2023. PMID: 36269406 Free PMC article. Review.
Idiopathic nephrotic syndrome is the most frequent pediatric glomerular disease, affecting from 1.15 to 16.9 per 100,000 children per year globally. ...Approximately 85-90% of patients attain complete remission of proteinuria within 4-6 weeks of treatment wit …
Idiopathic nephrotic syndrome is the most frequent pediatric glomerular disease, affecting from 1.15 to 16.9 per 100,00 …
Interventions for focal segmental glomerulosclerosis in adults.
Hodson EM, Sinha A, Cooper TE. Hodson EM, et al. Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD003233. doi: 10.1002/14651858.CD003233.pub3. Cochrane Database Syst Rev. 2022. PMID: 35224732 Free PMC article. Review.
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) can be separated into primary, genetic or secondary causes. Primary disease results in nephrotic syndrome while genetic and secondary forms may be associated with asymptomatic proteinuria or with nephrotic …
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) can be separated into primary, genetic or secondary causes. Primary disease results in …
Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K, Palmer SC, Strippoli GF, Hodson EM. Azukaitis K, et al. Cochrane Database Syst Rev. 2022 Mar 1;3(3):CD001537. doi: 10.1002/14651858.CD001537.pub5. Cochrane Database Syst Rev. 2022. PMID: 35230699 Free PMC article. Review.
The optimal agent, dose, and duration of treatment for the first episode of nephrotic syndrome, or for disease relapse(s) have not been determined. ...OBJECTIVES: We aimed to 1) evaluate the benefits and harms of different agents, including both immunosuppressive an …
The optimal agent, dose, and duration of treatment for the first episode of nephrotic syndrome, or for disease relapse(s) have …
Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
Hansrivijit P, Cheungpasitporn W, Thongprayoon C, Ghahramani N. Hansrivijit P, et al. BMC Nephrol. 2020 Apr 15;21(1):134. doi: 10.1186/s12882-020-01797-7. BMC Nephrol. 2020. PMID: 32293308 Free PMC article.
From the analysis of five studies with FSGS patients (n = 51), the overall remission rate and relapse rate of RTX therapy was 53.6% (95% CI, 15.8-87.6%) and 47.3% (95% CI, 25.4-70.2%), respectively. Complete remission occurred in 42.9%. ...
From the analysis of five studies with FSGS patients (n = 51), the overall remission rate and relapse rate of RTX therapy was 53.6% (95% CI, …
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
von Groote TC, Williams G, Au EH, Chen Y, Mathew AT, Hodson EM, Tunnicliffe DJ. von Groote TC, et al. Cochrane Database Syst Rev. 2021 Nov 15;11(11):CD004293. doi: 10.1002/14651858.CD004293.pub4. Cochrane Database Syst Rev. 2021. PMID: 34778952 Free PMC article. Review.
BACKGROUND: Primary membranous nephropathy (PMN) is a common cause of nephrotic syndrome in adults. Without treatment, approximately 30% of patients will experience spontaneous remission and one third will have persistent proteinuria. ...Immunosuppressive treatment …
BACKGROUND: Primary membranous nephropathy (PMN) is a common cause of nephrotic syndrome in adults. Without treatment, approxi …
Mercury-associated nephrotic syndrome: a case report and systematic review of the literature.
Miller S, Pallan S, Gangji AS, Lukic D, Clase CM. Miller S, et al. Am J Kidney Dis. 2013 Jul;62(1):135-8. doi: 10.1053/j.ajkd.2013.02.372. Epub 2013 Apr 18. Am J Kidney Dis. 2013. PMID: 23602193 Review.
Kidney injury from mercury is known to cause dose-related tubular dysfunction and idiosyncratic nephrotic syndrome according to various case reports. Motivated by a patient with subacute-onset nephrotic syndrome, histologic features of secondary focal …
Kidney injury from mercury is known to cause dose-related tubular dysfunction and idiosyncratic nephrotic syndrome according t …
Childhood nephrotic syndrome and the clinical profile of thromboembolism: a systematic review and meta-analysis.
Dadgar K, Xue Y, Chung J, Sangar S, Bhatt M, Chan AKC, Geddie H, Chanchlani R. Dadgar K, et al. Pediatr Res. 2023 May;93(6):1463-1469. doi: 10.1038/s41390-022-02302-6. Epub 2022 Sep 20. Pediatr Res. 2023. PMID: 36127405
Nephrotic syndrome (NS) is a common kidney disease of childhood, affecting 2-7 children per 100,000. ...IMPACT: The prevalence of symptomatic thromboembolic (TE) events in children with nephrotic syndrome (NS) was 3.60% (95% CI 1.95-5.63), which increa …
Nephrotic syndrome (NS) is a common kidney disease of childhood, affecting 2-7 children per 100,000. ...IMPACT: The prevalence …
Sphingosine phosphate lyase insufficiency syndrome: a systematic review.
Pournasiri Z, Madani A, Nazarpack F, Sayer JA, Chavoshzadeh Z, Nili F, Tran P, Saba JD, Jamee M. Pournasiri Z, et al. World J Pediatr. 2023 May;19(5):425-437. doi: 10.1007/s12519-022-00615-4. Epub 2022 Nov 12. World J Pediatr. 2023. PMID: 36371483 Review.
BACKGROUND: Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) or nephrotic syndrome type-14 is caused by biallelic mutations in SGPL1. ...Kidney disorders (42, 80.8%) were mainly in the form of steroid-resistant nephrotic syndrome (SR …
BACKGROUND: Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) or nephrotic syndrome type-14 is caused by bia …
Adverse reactions of Niaoduqing granules: A systematic review and meta-analysis.
Fu B, Shang Z, Song S, Xu Y, Wei L, Li G, Yang H. Fu B, et al. Phytomedicine. 2023 Jan;109:154535. doi: 10.1016/j.phymed.2022.154535. Epub 2022 Nov 9. Phytomedicine. 2023. PMID: 36610168 Free article. Review.
METHODS: The literature was searched in Embase, Medline via PubMed, Cochrane Library database, Wanfang database, Chinese National Knowledge Infrastructure, SinoMed, and Chinese VIP Database from inception to January 15, 2022, for randomized controlled trials (RCTs) and obs …
METHODS: The literature was searched in Embase, Medline via PubMed, Cochrane Library database, Wanfang database, Chinese National Knowledge …
Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis.
Zhu Y, Chen J, Zhang Y, Wang X, Wang J. Zhu Y, et al. Front Immunol. 2024 Feb 23;15:1310032. doi: 10.3389/fimmu.2024.1310032. eCollection 2024. Front Immunol. 2024. PMID: 38464533 Free PMC article.
AIM: This study aimed to systematically compare the efficacy of various immunosuppressive agents in treating pediatric frequently relapsing or steroid-dependent nephrotic syndrome (FRSDNS). METHODS: We conducted systematic searches of PubMed, Embase, the Cochrane Li …
AIM: This study aimed to systematically compare the efficacy of various immunosuppressive agents in treating pediatric frequently relapsing …
32 results